Related Experiment Videos
c-mpl, the thrombopoietin receptor
W Vainchenker1, N Methia, N Debili
1INSERM U 362, Institut Gustave Roussy, Villejuif, France.
Thrombosis and Haemostasis
|July 1, 1995
Summary
The Mpl receptor protein
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- The v-mpl oncogene is derived from the myeloproliferative leukemia virus (MPLV).
- The cellular homolog, c-mpl, encodes a cytokine receptor crucial for megakaryocytic differentiation.
- This receptor is primarily found in the megakaryocytic lineage.
Purpose of the Study:
- To identify and characterize the ligand for the Mpl receptor.
- To investigate the biological activities of the Mpl receptor ligand.
- To understand the role of the Mpl ligand in platelet production.
Main Methods:
- Isolation of cDNAs encoding the Mpl receptor ligand using the Mpl receptor protein.
- Expression and purification of recombinant Mpl ligand.
- In vitro and in vivo assays to determine biological activities.
Main Results:
- cDNAs for the Mpl receptor ligand were successfully isolated from humans, pigs, dogs, and mice.
- The recombinant Mpl ligand demonstrated both thrombopoietin (TPO) and megakaryocyte-colony stimulating factor (MK-CSF) activities.
- These findings suggest a unified role for the Mpl ligand.
Conclusions:
- The Mpl ligand, also known as TPO/MK-CSF, is a key regulator of platelet production.
- This molecule appears to be the primary humoral factor controlling thrombopoiesis.
- The identification of this ligand has significant implications for understanding and treating platelet disorders.